IFNA1 and systemic lupus erythematosus: To investigate whether in vivo exposure of B cells to high levels of IFN-α released by chronically activated pDCs could explain the reduced frequency of IL-10+ B cells in SLE, B cells were stimulated with CpGC and increasing doses of IFN-α.